| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.3 |